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1. Introduction 
Diabetic retinopathy (DR) is one of the leading causes of decreased vision and blindness in 
industrialized countries (Bhavsar, 2002). Much of the retinal damage that characterizes 
advanced proliferative diabetic retinopathy (PDR) results from retinal neovascularization 
(Simo, et al., 2006). When the newly formed vessels are associated with fibrous 
proliferations that form fibrovascular membranes (FVMs) on the surface of the neuroretina, 
traction retinal detachments can develop, resulting in potentially severe loss of vision 
(Hiscott, et al., 2000). 
FVMs are characterized by the migration and proliferation of various types of cells, e.g., 
retinal glial cells, fibroblasts, macrophages/monocytes, hyalocytes, laminocytes, and 
vascular endothelial cells. It has been postulated that the formation of FVMs represents a 
wound healing process (Hiscott, et al., 2000). To date, the factors regulating the 
development and progression of FVMs have not been fully determined. Moreover, despite 
improvements in vitreal surgical techniques, panretinal photocoagulavtion, and the use of 
intravitreal anti-VEGF drugs such as Ranibizumab, the prognosis for DR is still poor 
especially in advanced cases of PDR. It is therefore required to develop better treatments 
that are based on the pathogenesis of FVMs.  
2. Conventional studies investigating the mechanisms of FVM formation  
Earlier conventional studies investigating the molecular effects of FVM formation have 
focused mainly on one or a few molecules or pathways. Several molecules, e.g., vascular 
endothelial growth factor (VEGF), tumor necrosis factor-ǂ (TNF- ǂ), basic fibroblast growth 
factor (bFGF), intereleukin-8 (IL-8), apelin, tumor endothelial marker 7 (TEM7), monocyte 
chemoattractant protein-1 (MCP-1;CCL2), erythropoietin, angiopoietin-2, advanced 
glycation end product, nuclear factor kappa-B, and activator protein-1 have been detected in 
FVMs and/or vitreous fluid collected from patients with PDR (Simo, et al., 2006; Yoshida, et 
al., 1998; Yoshida, et al., 1999; Yoshida, et al., 2010; Watanabe, et al., 2005).  
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Retinal hypoxia is assumed to be the common mechanism which initiates a series of events 
leading to retinal neovascularization (Ishikawa, et al., 2010). Cellular inflammation is 
initiated at the blood-microvascular endothelial-cell interface, and leukocytic infiltration has 
been observed after retinal hypoxia. Several mediators of retinal neovascularization have 
been determined in well-established murine models of oxygen-induced retinopathy (OIR) 
(Smith, et al., 1994). 
Chemokines, a family of structurally related cytokines involved in the activation and 
directed migration of leukocytes, may be pathophysiologically key mediators of 
inflammation (Singh, et al.). Two well-studied CC chemokines are MCP-1 and macrophage 
inflammatory protein-1ǂ (MIP-1ǂ;CCL3). Both MCP-1 and MIP-1ǂ have been shown to 
mediate the recruitment of leukocytes and induction of neovascularization in several 
inflammatory diseases. 
 
Fig. 1. Northern blot determination of mRNA expression of MCP-1, MIP-1ǂ, and VEGF in 
murine OIR. Representative blots of three independent experiments are shown. Lane 1, 
Control retina (P12); lane 2, retina after 5 days exposure to hyperoxia (P12); lane 3, retina 12 
h after hypoxia (P12.5). For control, the same blot was stripped and reprobed with GAPDH, 
and 18 S and 28 S ribosomal RNA were used for equal loading of RNA. Each lane contains 
10 µg total RNA. Reproduced with permission from Yoshida et al. [17] 
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In order to determine the role played by MCP-1 and MIP-1ǂ, we have investigated whether 
these chemokines can be induced in murine OIR (Singh, et al.). The expression of the 
mRNAs of MCP-1 and MIP-1ǂ was very low or undetectable in the retinas of the normal 
controls and in P12 mice killed just 5 days after hyperoxia (Fig. 1). A dramatic increase in 
MCP-1 mRNA expression was observed 12 h after the onset of hypoxia. The profile of MIP-
1ǂ mRNA expression was similar to that of MCP-1 mRNA, except that a slight increase of 
MIP-1ǂ mRNA was detected in the retinas of mice 5 days (P12) after hyperoxia.  
In contrast to MCP-1 and MIP-1ǂ, a steady level of VEGF mRNA expression was found in 
the retinas of control, normal mice (Fig. 1). Hyperoxia resulted in a significant down-
regulation in the level of VEGF mRNA, and the subsequent hypoxia led to a significant up-
regulation of VEGF expression compared with that in the control retinas.  
 
Fig. 2. In situ hybridization for MCP-1 and MIP-1ǂ in the retinas of murine OIR. 
Hybridization was performed with antisense (A, B, D, E) or sense (C, F) probes specific for 
MCP-1 (A–C) and MIP-1ǂ (D–F). A, D, Control normal retina (P12); B, C, E, and F, retina 12 
h after hypoxia (P12.5). GCL, Ganglion cell layer; INL, inner-nuclear layer; ONL, outer-
nuclear layer. Original bar = 50 µm. Reproduced with permission from Yoshida et al. [17] 
In retinal hypoxia, the inner retina, which is supplied by retinal vessels, is hypoxic, whereas 
the outer retina, supplied by the choroidal vessels, is not. In situ hybridization for MCP-1 
and MIP-1ǂ showed a prominent increase of positive cells located in the inner retina 12 h 
after the hypxia (P12.5) in comparison to the lower level of staining in the nonhypoxic 
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retinas of control mice (Fig. 2). The inner retinal layer where ganglion cells and astrocytes 
are located was the most prominent cellular site of MCP-1 and MIP-1ǂ gene expression in 
the hypoxic inner retina. This suggests that MCP-1 and MIP-1ǂ expressed in this region 
attract resident microglia, hyalocytes, and/or bone marrow-derived monocyte lineage cells 
(BM-MLCs) through the blood-retinal barrier toward the superficial layer of the retina 
where neovascularization occurs.  
Among the environmental stimuli, gene expression by macrophages/BM-MLCs following 
hypoxia is becoming increasingly well-characterized to have angiogenic potential(Lewis, et 
al., 2007). In murine OIR, macrophages/BM-MLCs in the ischemic retina exhibited thicker 
and more distended processes compared with those in normal, control retinas (Ishikawa, et 
al., 2011). We assume that such "hypoxia-activated" BM-MLCs have the potential to produce 
an array of angiogenic cytokines and growth factors including TNF-ǂ and VEGF, which can 
contribute to the progression of retinal neovascularization/revascularization. TNF-ǂ is an 
angiogenic molecule produced by hypoxic monocytes/macrophages (Yun, et al., 1997) and 
is a likely mediator of retinal neovascularization/revascularization. It has been reported that 
TNF-ǂ level is higher in patients with PDR(Limb, et al., 2001), and we have detected this 
molecule in the macrophages/BM-MLCs in murine OIR (Yoshida, et al., 2004). Moreover, 
we have demonstrated that TNF-ǂ up-reguletes the production of IL-8, VEGF, bFGF, or 
MCP-1 in retinal vascular cells and/or glial cells adjacent to microvessels triggering 
neovascularization/revascularization in an autocrine or paracrine manner (Yoshida, et al., 
2004; Yoshida, et al., 1997). These processes are likely to be important in promoting 
macrophages/ BM-MLCs-related retinal neovascularization/revascularization in hypoxic 
retinas. 
3. Global gene expression profiling of FVMs 
Despite earlier studies investigating the molecular effects of retinal hypoxia, the molecular 
events taking place in hypoxic retinas that may lead to retinal neovascularization remain 
undetermined. The recent technological advancements in genomics, such as advent of 
microarray technology, have opened up new avenues to identify all the genes and their 
products that are expressed in a particular tissue. 
To determine the factors that are activated during retinal hypoxia, we performed a gene 
expression profiling of hypoxic retinas obtained from a murine OIR using gene microarray 
thechnology(Ishikawa, et al., 2010). Our analyses showed that retinal hypoxia were 
associated with specific changes in the patterns of gene expression. These alterations may 
reflect the postischemic inflammation, and subsequent neural and vascular remodeling, and 
pathologic neovascularization in retinas of murine OIR (Fig. 3).  
Several genes reported to be involved in retinal hypoxia, such as Vegfa(Yoshida, et al., 2003), 
Hif1a(Ozaki, et al., 1999), and Mip1┙(Ccl3)(Yoshida, et al., 2003), were also detected to be 
differentially expressed in the hypoxic retina in our study, confirming that our microarray 
analyses were trustworthy. Interestingly, the most up-regulated gene among the 
differentially-expressed genes in hypoxic retinas was the Mip1┚(Ccl4) and not Vegfa and 
other chemokines. 
www.intechopen.com
Fibrovascular Membranes Associated with PDR:  
Development of Molecular Targets by Global Gene Expression Profiling 113 
  
Fig. 3. Distribution of Gene Ontology terms in genes regulated by hypoxic retinas. Ontology 
of genes upregulated by hypoxia. Reproduced with permission from Ishikawa et al. [8] 
MIP-1ǃ (CCL4) is a member of the CC chemokine family that are characterized by their 
ability to direct migration of leukocytes into inflamed tissue. MIP-1ǃ was first isolated from 
the culture medium of LPS-activated macrophages, and it recruited macrophages/microglia 
to sites of injury in patients with sepsis, arthritis, and systemic sclerosis. Because MIP-1ǃ is 
not known to be a hypoxia-responsive gene in the retina, it may play more roles in hypoxic 
retinas than previously envisaged. Therefore, further studies are required to determine the 
role played by MIP-1ǃ in hypoxia-induced retinal neovascularization/revascularization 
(Ishikawa, et al., 2011). 
Expressed sequence tag (EST) analysis, another method of global gene expression profiling, 
permit the identification of genes expressed in particular tissues in a completely 
unambiguous manner (Wistow, 2006). ESTs may also reveal comprehensive data on 
transcript and gene variants. These represent important sources for the search for as yet 
incompletely characterised genes and pathways as exemplified by the NEIBank project in 
the eye research field (Wistow, 2006). We hypothesized that a comprehensive analysis of 
gene expression in FVMs may open up new avenues in enhancing our understanding of the 
formation of FVMs, and such an effort should lead to further advances in the surgical and 
medical treatment of FVMs (Yoshida, et al., 2010).  
To overcome the limitation of the starting amount of RNA from the FVMs obtained from 
patients with PDR, We chose to employ Switching Mechanism at the 5′ end of RNA 
Transcript (SMART) technology, an exponential PCR-based technology. With this 
technology, we have successfully constructed a complementary DNA (cDNA) library from 
the FVMs and sequenced more than 2800 cDNAs (Yoshida, et al., 2010). We next performed 
sequence similarity searches to compare every EST to those in public databases. For ESTs 
with known gene matches in public databases, functional annotation was retrieved from the 
human cDNA database (Ensembl) and analysed by FatiGO.  
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Among the 625 non-redundant clusters, 515 (82%) matched Ensembl. The remaining 110 
(17%) corresponded to potentially novel ESTs or untranslated sequences. Among those 
database-matched, 515 clusters were subdivided by functional subsets of genes related to 
ribosomal activity, oxidative phosphorylation, focal adhesion, cell adhesion, and other 
functions by FatiGO analysis (Fig. 4). This suggests that many subsets of functional genes 
are expressed in FVMs. Thus, there are many complex interactions among the molecules 
that are encoded by those genes. Among these, ferritin, light polypeptide (FTL) and 
metastasis associated lung adenocarcinoma transcript 1 (MALAT1) appeared to be the most 
abundant transcripts in the FVMs (Yoshida, et al., 2010). 
 
Fig. 4. The known human genes identified in the human fibrovascular membranes (FVMs) 
are grouped according to the Kyoto Encyclopedia of Genes and Genomes (KEGG) functional 
categories. Reproduced with permission from Yoshida et al. [20] 
The importance of the production of extracellular matrix by FVMs is well recognized 
(Hiscott, et al., 1999). In agreement with this notion, functional annotation of ESTs 
determined that those genes related to cell adhesions and focal adhesions are highly 
expressed in FVMs. Until now, among the components in extracellular matrix, type II 
collagen, SPARC and FN, major components of the vitreous, are well-known molecules. 
However, our EST analysis demonstrated the expression of COL1A2, COL3A1, MXRA8, and 
others, in addition to FN, SPARC as cellular adhesion components. This indicates that cells 
that comprise the FVM actively produce a variety of adhesion molecules and are actively 
involved in cell migration and proliferation (Yoshida, et al., 2010).  
www.intechopen.com
Fibrovascular Membranes Associated with PDR:  
Development of Molecular Targets by Global Gene Expression Profiling 115 
4. Development of molecular targets by global gene expression profiling of 
FVMs 
Recently, several trials of anti-VEGF therapy such as Ranibizmab have been applied on 
patients with intraocular neovascular diseases. However, undesirable side effects including 
brain and retinal vein occlusion have been reported (von Hanno, et al., 2010). Therefore, 
identifying the other molecular targets that can be treated less invasively is definitely still a 
goal. Because we were able to determine the existence of several potential factors other than 
VEGF by global gene expression profiling of FVMs (Yoshida, et al., 2010), we postulate that 
some of the extracted genes may be additional novel candidates for molecular targeting 
therapy. Among newly identified genes from FVMs, we found that tumor endothelial 
marker 7 (TEM7) and periostin were expressed more strongly in FVMs than in idiopatic 
epiretinal membranes (ERMs) (Yoshida, et al., 2011; Yamaji, et al., 2008). This led us to 
hypothesize that these two molecules play key roles in the maintenance and/or 
development of FVMs. 
a. Tumor endothelial marker 7 (TEM7) 
As described earlier, recent technological improvements in cellular fractionation and 
genomics have led to the identification of several markers preferentially expressed on 
vascular endothelial cells of human tumors (Nanda and St Croix, 2004). Among these 
markers, the tumor endothelial markers (TEMs) are a group of cell surface proteins 
preferentially expressed on the endothelial cells of various cancer cells.  
Of these cell surface markers, TEM7, also known as plexin domain-containing 1 (PLXDC1), 
is especially attractive because it is the most abundant isoform among the TEMs. TEM7 
protein is overexpressed in the neovascular vessels of human solid tumors such as lung, 
colon, and esophageal cancers (Nanda and St Croix, 2004). The full-length form of TEM7 has 
sequence characteristics of cell surface proteins, including signaling peptides, plexin-
semaphorin-integrin (PSI) domain, and transmembrane domain(s). In addition, TEM7 is 
expressed as a complex pattern of transcripts derived by alternative splicing with 
potentially different activities and biological functions. These transcripts are predicted to be 
intracellular (TEM7-I), secreted (TEM7-S), or on the cell surface membrane (TEM7-M) of the 
endothelial cells of tumors.  
We asked whether the mRNA of TEM7 is expressed in the neovascular endothelial cells of 
FVMs surgically removed from patients with PDR (Fig. 5) (Yamaji, et al., 2008). The mRNA 
of TEM7 was enhanced in 10 of 10 FVMs obtained from PDR patients but was barely 
detected in the five idiopathic ERMs (control). In addition, RT-PCR with specific primer 
pairs yielded multiple bands suggesting the presence of splice variants of TEM7 in the 
FVMs. The mRNAs of IL-8 were detected in 10 of 10 FVM specimens, VEGF in 8 of 10 FVM 
specimens, and VEGFR2 in 9 of 10 FVM specimens. In contrast to TEM7, these 3 angiogenic 
molecules were also upregulated in some of the control idiopathic ERMs (3 of 5, 3 of 5, and 2 
of 5, respectively). 
To determine the location of the protein of TEM7 in FVMs, we next double-stained the FVM 
sections with an anti-TEM7 monoclonal antibody (IM193), which specifically detects TEM7-
M, and an antibody to CD34, an endothelial cell marker (Fig. 6). Consistent with previous 
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results on the staining patterns of tumors with neovascularization (Nanda and St Croix, 
2004), the antibody specifically labeled the neovascular endothelial cells in the FVMs (Fig. 6). 
 
Fig. 5. RT-PCR analysis of TEM7, IL-8, VEGF, VEGFR2, and GAPDH in fibrovascular 
membranes derived from patients with proliferative diabetic retinopathy (PDR; patients 1–
10) and in epiretinal membranes from eyes with idiopathic epiretinal membranes (iERMs; 
patients 11–15). After 35 cycles, 8 μL each sample was electrophoresed through a 2% Tris-
acetate-EDTA agarose gel, and the fractionated products were stained with ethidium 
bromide. Note the distinct high expression of the mRNA of TEM7 in the fibrovascular 
membranes derived from patients with PDR compared with control iERMs. Reproduced 
with permission from Yamaji et al. [24] 
 
Fig. 6. Double staining for TEM7 and CD34 in the FVM. (A) Neovascular endothelial cells 
are visible after specific staining with CD34 in the FVM. (B) Specific staining for TEM7 in the 
same section shows an identical staining pattern. (C) Double staining for TEM7 and vascular 
endothelial cells in the same sample shows positive cells for both antibodies. The yellow 
staining is caused by the overlapping of the red and the green colors, showing colocalization 
of TEM7-M with the pan-endothelial marker CD34. Sale bars, 50 μm. Reproduced with 
permission from Yamaji et al. [24] 
To determine a more exact location of the TEM7 protein within the neovascular endothelial 
cells, we performed immunoelectron microscopy using monoclonal anti-TEM7 antibody 
(IM193). Electron microscopy revealed that TEM7-M was expressed at the tight junctions 
and at the luminal surfaces of the vascular endothelial cells (Fig. 7) 
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Fig. 7. TEM7 staining for transmission electron microscopy with IM193 antibody to detect 
TEM7-M. Staining is observed on the tight junctions (arrows) and on the luminal surfaces of 
endothelial cells (ECs; arrowheads). Scale bar, 200 nm. Reproduced with permission from 
Yamaji et al. [24] 
Considerable effort has been invested recently to develop agents that block the formation of 
new blood vessels. For example, Bebacizumab, a selective VEGF inhibitor, was recently 
found to be effective in the regression of retinal and iris neovascularization secondary to 
PDR, but because of its cytostatic property, its effect may be limited to established 
vasculature. Therefore, it has become apparent that targeted destruction of the established 
vasculature is another option for therapeutic opportunities. In this regard, the presence of 
membrane-bound TEM7 on the luminal surfaces of neovascular endothelial cell is of interest 
(Fig. 7). Recently, cortactin, a monomeric protein that can be activated by external stimuli to 
promote polymerization and rearrangement of the actin cytoskeleton, and nidogen, a 
component of the basement membrane, were identified as proteins capable of binding to the 
extracellular region of TEM7 (Lee, et al., 2006; Nanda, et al., 2004). Because the retinal 
vessels are the only vessels that can be observed in situ, it may be possible to use a more 
selective ligand-based neovascular endothelial cell targeting strategy by delivering the 
bioactive molecules to the blood-retinal neovascular endothelial interface. For example, 
photodynamic therapy using such TEM7-binding partners labeled with photosensitive 
biomolecules may open new possibilities for a lower invasive therapy of retinal 
neovascularization.  
b. Periostin 
Periostin is a matricellular protein and is a member of the fasciclin family (Takeshita, et al., 
1993). It contains an N-terminal secretory signal peptide, followed by a cysteine-rich 
domain, four internal homologous repeats, and a C-terminal hydrophilic domain (Horiuchi, 
et al., 1999). The high degree of structural and sequence homology of periostin with fasciclin 
1 and transforming growth factor ǃ–induced (TGFBI) suggests that periostin plays a role in 
cell adhesion and migration (Horiuchi, et al., 1999). In addition, periostin is expressed as a 
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complex pattern of transcripts derived by alternative splicing with potentially different 
activities and biological functions (Yoshida, et al., 2011).  
Periostin expression is altered in different diseases, including neoplasias, cardiovascular 
disease, and wound repair (Kanno, et al., 2008). Periostin is overexpressed in various human 
cancers such as pancreas, colon, ovary, oral squamous cell carcinoma, and lung, and its 
overexpression is correlated with the aggressiveness of the tumor and with poorer survival. 
Moreover, tumor cell lines engineered to overexpress periostin have accelerated the growth 
and higher angiogenic and metastatic potential in immunocompromised animals. In the 
heart, periostin plays a key role in the progression of cardiac valve complex degeneration by 
inducing angiogenesis and MMP production (Hakuno, et al., 2010). Periostin is also an 
element of bone marrow fibrosis and subepithelial fibrosis of bronchial asthma (Takayama, 
et al., 2006).  
 
Fig. 8. Periostin levels in vitreous samples from eyes with nondiabetic (epiretinal membrane 
and macular hole) ocular diseases and eyes with proliferative diabetic retinopathy. ERM, 
epiretinal membrane. *P < 0.001. Reproduced with permission from Yoshida et al. [23] 
We examined the amount of periostin in the 106 vitreous samples of patients with PDR 
collected during vitrectomy, and in the 31 vitreous samples obtained from patients during 
macular hole or ERM surgery (Yoshida, et al., 2011). We found that the concentration of 
periostin in the vitreous of patients with PDR was significantly higher than that in the 
vitreous of patients without PDR (Fig. 8). The concentration of periostin in the vitreous of 
patients with PDR was significantly correlated with the presence of FVMs but that of VEGF 
was not correlated (Yoshida, et al., 2011). The differences in the correlations between 
periostin and VEGF are probably because VEGF is upregulated in the retina at an earlier 
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stage in response to hypoxia before the fromation of FVMs (Ishikawa, et al., 2010; Yoshida, 
et al., 2003).  
Immunohistochemical analyses with the anti-periostin antibody revealed that periostin was 
expressed in the vascular pericytes that were ǂ-SMA positive (Yoshida, et al., 2011). 
Periostin is reported to promote angiogenesis by an up-regulation of the VEGF receptor, 
Flk-1/KDR, by endothelial cells through an integrin ǂVǃ3-focal adhesion kinase-mediated 
signaling pathway (Shao, et al., 2004). This suggests that periostin may play a role in 
promoting and/or maintaining vasculature in FVMs in a paracrine fashion. In addition, 
periostin was also expressed in myofibroblast-like cells in the stroma of FVMs (Yoshida, et 
al., 2011). It has been reported that a stable expression of a periostin in 293T cells causes the 
cells to undergo fibroblast-like transformation, and the cells expressing ectopic periostin 
increased cell migration, invasion, and adhesion (Yan and Shao, 2006). These findings 
suggest that periostin-expressing myofibroblast-like cells may play a role in the invasive 
properties of FVMs. Taken together, these results indicate that periostin may play specific 
roles in the formation and/or maintenance of FVMs.  
 
Fig. 9. RT-PCR analyses of periostin (POSTN), VEGF, VEGFR2, and GAPDH in FVMs 
derived from patients with proliferative diabetic retinopathy (PDR; lanes 4–13) and from 
control retinas (lanes 1–3). After 35 cycles, 8 μL each sample was electrophoresed through a 
2% Tris-acetate-EDTA agarose gel, and the fractionated products were stained with 
ethidium bromide. Note the high expression of the mRNA of periostin with multiple bands 
in the FVMs derived from patients with PDR compared with control retinas. Reproduced 
with permission from Yoshida et al. [23] 
Alternative splicing events occur within the C-terminal region of periostin, which is a key 
region that regulates cell invasiveness and metastasis (Shimazaki and Kudo, 2008). We 
confirmed that three spliced variants and the WT of human periostin were present in FVMs 
(Fig. 9) and that the periostin splice variant specifically regulated ǂ-SMA gene expression 
(Yoshida, et al., 2011). It is suggested that the ǃ strands within the C-terminal region may 
mediate binding interactions with other proteins such as FN or collagen. Because cell-
specific isoform profiles and isoform-specific biological properties of periostin have been 
demonstrated (Shimazaki and Kudo, 2008), the existence of the different isoforms of 
periostin in FVMs may be used to vary the binding properties of periostin to other ECM 
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proteins. This can then result in the deregulation of crucial cellular processes such as 
adhesion, proliferation, differentiation, and invasion. Unraveling the role of alternative 
splicing of periostin in the formation of FVMs may yield the basis for the development of 
isoform-specific molecular targeting therapeutic strategies.  
5. Conclusion 
By applying global gene expression technology to FVMs and hypoxic retinas, we have 
successfully identified novel genes that may play key roles in the formation and/or 
maintenance of FVMs. We believe that the transcriptome analyses performed in our studies 
may provide valuable information and thus should facilitate a wide range of future studies 
to establish tissue-specific molecular mechanisms associated with formation of FVMs.  
As described earlier, recently-introduced anti-VEGF therapy on patients with intraocular 
neovascular diseases can reportedly accompany undesirable side effects such as brain and 
retinal vein occlusion. This was partly attributed to a steady level of VEGF expression in the 
normal retina, suggesting a role of VEGF in keeping normal homeostasis of the retina (Fig. 
1) (Yoshida, et al., 2011). The manipulation of the VEGF pathway to inhibit pathologic 
neovascularization could result in unexpected disturbances of the normal homeostasis in the 
retina and thus should be approached carefully.  
Because the vitreous concentrations of periostin were not significantly correlated with those 
of VEGF in the patients with PDR (Yoshida, et al., 2011), it may be inferred that periostin 
and VEGF do not act in a directly synchronized manner in the formation of FVMs. 
Moreover, in contrast to VEGF, periostin and TEM7 is assumed to be nonfunctional in 
normal retinas, in keeping with the very low levels of periostin in the normal control retinas 
(Fig. 9; (Yamaji, et al., 2008)). These results raise the possibility that the two molecules might 
be a potential therapeutic target to regulate “disease-specific” pathways in the formation of 
FVMs while minimizing the unfavorable side effects to the normal retina. Therefore, 
modulating the expression of periostin and/or TEM7 by antibodies or antisense 
oligonucleotides directed against the molecule could be a novel therapeutic strategy for 
inhibiting the progression of FVMs associated with PDR. 
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